0 Évaluations
ID

21925

Description

The present pharmacokinetic study is designed to assess the pharmacokinetics of RSG XR as monotherapy in patients with mild Alzheimer's disease (AD) as such information will not be obtained from the current phase III trials . The study aims to enroll fourteen patients (seven of each APOE genotype). Each patient will receive a single oral dose of 4mg of RSG XR in the morning under fasted conditions and PK samples will be taken up to 36h. GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1

Lien

https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1

Mots-clés

Versions (2)
  1. 08/05/2017 08/05/2017 -
  2. 20/05/2017 20/05/2017 -
Téléchargé le

8 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

    Anglais

    Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

    1 Formulaires  
    Concomitant Medication
    Description

    Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    Were any concomitant medications taken by the subject during the study? if YES record each medication on a separate line using Trade Names where possible. If yes, record each medication on a separate line using Trade Names where possible.
    Description

    Concomitant Medication

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2347852
    Medication
    Description

    Medication

    Alias
    UMLS CUI-1
    C0013227
    Drug name (Trade Name preferred) e.g. Aspirin
    Description

    Drug name

    Type de données

    text

    Alias
    UMLS CUI [1]
    C0013227
    Unit Dose e.g. 200
    Description

    Unit Dose

    Type de données

    float

    Alias
    UMLS CUI [1]
    C0869039
    Units* (eg. mg)
    Description

    Units

    Type de données

    text

    Alias
    UMLS CUI [1]
    C1519795
    Frequency* (e.g. BID)
    Description

    Frequency

    Type de données

    text

    Alias
    UMLS CUI [1]
    C3476109
    Route* (e.g. PO)
    Description

    Route

    Type de données

    text

    Alias
    UMLS CUI [1]
    C0013153
    Reason for Medication (e.g. Headache)
    Description

    Reason for Medication

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C0392360
    UMLS CUI [1,2]
    C0013227
    Start Date (e.g. 31 May 03)
    Description

    Start Date

    Type de données

    date

    Alias
    UMLS CUI [1]
    C0808070
    Start time (e.g. 14:10)
    Description

    Start time

    Type de données

    time

    Unités de mesure
    • hh:min
    Alias
    UMLS CUI [1]
    C1301880
    hh:min
    Taken Prior to Study? (e.g. N)
    Description

    Taken Prior to Study

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2826667
    Stop Date (e.g. 31 May 03)
    Description

    Stop Date

    Type de données

    date

    Alias
    UMLS CUI [1]
    C0806020
    Stop Time (e.g. 23:00)
    Description

    Stop Time

    Type de données

    time

    Alias
    UMLS CUI [1]
    C1522314
    Ongoing Medication? (e.g. N)
    Description

    Ongoing Medication

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2826666
    Retour au début de la page

    Similar models

    Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    Concomitant Medication
    C2347852 (UMLS CUI-1)
    Concomitant Medication
    Item
    Were any concomitant medications taken by the subject during the study? if YES record each medication on a separate line using Trade Names where possible. If yes, record each medication on a separate line using Trade Names where possible.
    boolean
    C2347852 (UMLS CUI [1])
    Item Group
    Medication
    C0013227 (UMLS CUI-1)
    Drug name
    Item
    Drug name (Trade Name preferred) e.g. Aspirin
    text
    C0013227 (UMLS CUI [1])
    Unit Dose
    Item
    Unit Dose e.g. 200
    float
    C0869039 (UMLS CUI [1])
    Units
    Item
    Units* (eg. mg)
    text
    C1519795 (UMLS CUI [1])
    Frequency
    Item
    Frequency* (e.g. BID)
    text
    C3476109 (UMLS CUI [1])
    Route
    Item
    Route* (e.g. PO)
    text
    C0013153 (UMLS CUI [1])
    Reason for Medication
    Item
    Reason for Medication (e.g. Headache)
    text
    C0392360 (UMLS CUI [1,1])
    C0013227 (UMLS CUI [1,2])
    Start Date
    Item
    Start Date (e.g. 31 May 03)
    date
    C0808070 (UMLS CUI [1])
    Start time
    Item
    Start time (e.g. 14:10)
    time
    C1301880 (UMLS CUI [1])
    Taken Prior to Study
    Item
    Taken Prior to Study? (e.g. N)
    boolean
    C2826667 (UMLS CUI [1])
    Stop Date
    Item
    Stop Date (e.g. 31 May 03)
    date
    C0806020 (UMLS CUI [1])
    Stop Time
    Item
    Stop Time (e.g. 23:00)
    time
    C1522314 (UMLS CUI [1])
    Ongoing Medication
    Item
    Ongoing Medication? (e.g. N)
    boolean
    C2826666 (UMLS CUI [1])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial